Cryoport, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cryoport, Inc. on January 13, 2010, reporting events that occurred on January 7, 2010. The filing addresses corporate governance changes, specifically the expansion of the Board of Directors and the appointment of a new director.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial details disclosed relate to the compensation package for the newly appointed director:
- Stock Option Grant: 34,076 shares of common stock at an exercise price of $0.57 per share.
- Vesting Schedule: Three quarterly installments commencing January 31, 2010.
- Cash Compensation: Quarterly board fee of $15,000.
Material Changes
The primary material change reported is the increase in the size of the Board of Directors from three to four members. John H. Bonde was elected to fill the new vacancy and appointed to the Audit Committee. There were no related party transactions or undisclosed arrangements regarding his selection.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The document is strictly limited to the disclosure of the director appointment and associated compensatory arrangements.
Investor Verification Checklist
- Verify the vesting schedule and exercise price of the 34,076 stock options granted to John H. Bonde.
- Confirm the quarterly cash board fee obligation of $15,000.
- Review the attached press release (Exhibit 99.1) for additional context on the appointment.
- Note that this filing does not contain updated financial statements or operational metrics.